Table 2.
Scores of MG-ADL and QMG during follow-up periods.
| Scores, median (IQR) | |||||
|---|---|---|---|---|---|
| Baseline | 1 month | 3 months | 6 months | 12 months | |
| MG-ADL | |||||
| Overall | 6 (4–7.75) | 4 (2.75–6) | 3 (1–4) | 2 (0–3.25) | 1 (0–2) |
| In OMG | 5 (3–6) | 3(2–5) | 2.5 (1–3.75) | 1.5 (0–3) | 1 (0–3) |
| In GMG | 7 (5–10) | 5(4–7) | 3 (1–4) | 2 (0–4) | 0.5 (0–2) |
| QMG | |||||
| Overall | 7 (6–10) | - | - | 3 (1–6) | 3(1–3) |
| In OMG | 6 (4–6) | - | - | 1 (0.5–3.5) | 1(0–3.75) |
| In GMG | 10 (7–11.5) | - | - | 5.5 (1–6.25) | 3(1–3) |
IQR, interquartile range; MG-ADL, myasthenia gravis-specific activities of daily living scale; QMG, quantitative myasthenia gravis score; MG-ADL, myasthenia gravis activities of daily living; OMG, ocular myasthenia gravis; GMG, generalized myasthenia gravis.